Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs interscalene brachial plexus block for postoperative recovery after shoulder arthroscopy
ChiCTR2400093913Phase 4Suspended
- Sponsor
- Taixing People's Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in Shoulder disorder (2 arms), sponsored by Taixing People's Hospital. Primary endpoint: Postoperative QoR-15 score. Started Dec 2024; status: suspended.
02
Drugs
ropivacaine
03
Conditions
Shoulder disorder
Beyond the preview
Go deeper on ChiCTR2400093913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093913.